Physiologic Assessment of Microvascular Function in Heart Transplant Patients
ConditionCardiac Allograft Vasculopathy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorSamsung Medical Center
About this trial
The aim of the study is to evaluate the impact of early microvascular disease assessed by coronary physiologic indices such as fractional flow reserve (FFR), coronary flow reserve (CFR), index of microvascular resistance (IMR) on future occurrence of cardiac allograft vasculopathy (CAV) in heart transplant recipients.
Eligibility criteria
Qualifiers
Subject over age of 18
Patients received heart transplant
Disqualifiers
Patients with cardiogenic shock
Patients with unstable vital sign that precludes coronary angiography
Patients with major bleeding in last 3 months
Patients with active bleeding
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov